价格

Rett syndrome therapy

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT
- EP 3555100 B1
  申请人: AGENEBIO INC优先权: 2016
  CN
  EP
  US
  WO
  9 件公开
- EP 3083569 B1
  申请人: AGENEBIO INC优先权: 2013
  CN
  EP
  US
  6 件公开
- US 10815242 B2
  申请人: AGENEBIO INC优先权: 2015
  CN
  US
  4 件公开
- US 11414425 B2
  申请人: AGENEBIO INC优先权: 2019
  US
  2 件公开
RETT SYNDROME AND TREATMENTS THEREFORE
EP 3013371 A4申请人: RETT SYNDROME RES TRUST优先权: 2013
CN
EP
US
WO
4 件公开
AAV-MEDIATED TARGETING OF MIRNA IN THE TREATMENT OF X-LINKED DISORDERS
EP 4107266 A1申请人: RES INST NATIONWIDE CHILDRENS HOSPITAL优先权: 2020
CN
EP
US
WO
4 件公开
MECP2 BASED THERAPY
US 2021101938 A1申请人: UNIV COURT UNIV OF EDINBURGH优先权: 2017
CN
US
WO
4 件公开
COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF METHYL-CPG BINDING PROTEIN 2 (MECP2)
EP 4377460 A1申请人: TUNE THERAPEUTICS INC优先权: 2021
EP
US
WO
3 件公开
GENE THERAPY FOR RETT SYNDROME
EP 4715058 A4申请人: GENECOMBIO LTD优先权: 2023
CN
EP
WO
3 件公开
COMPOSITIONS FOR RESTORING MECP2 GENE FUNCTION AND METHODS OF USE THEREOF
US 20250312486 A1申请人: HOPE CITY优先权: 2022
US
WO
2 件公开
SYSTEMS, COMPOSITIONS, AND METHODS FOR MODULATING EXPRESSION OF METHYL-CPG BINDING PROTEIN 2 (MECP2) AND X-INACTIVE SPECIFIC TRANSCRIPT (XIST)
US 20260226118 A1申请人: TUNE THERAPEUTICS INC优先权: 2023
US
WO
2 件公开
Synthetic MeCP2 sequence for protein substitution therapy
US 8226930 B2申请人: LACCONE FRANCO ANTONIO优先权: 2006
US
2 件公开
DNA METHYLTRANSFERASE INHIBITORS FOR RETT SYNDROME THERAPY
EP 3207932 A1申请人: UNIV STUTTGART优先权: 2016
EP

药物

Rett syndrome therapy

专利

BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT